98 related articles for article (PubMed ID: 3045067)
1. Ceftazidime combined with mecillinam: serum bactericidal titres compared with in-vitro synergy against gram-negative bacilli.
Van der Auwera P; Vandermies A; Lieppe S; Grenier P; Bourguignon AM; Ernst F
J Antimicrob Chemother; 1988 Jun; 21(6):745-53. PubMed ID: 3045067
[TBL] [Abstract][Full Text] [Related]
2. Inducing capacity of the combinations mecillinam-ampicillin and mecillinam-ceftazidime in comparison with the capacity of the compounds administered separately.
Stobberingh EE; van Boven CP
Chemotherapy; 1987; 33(2):97-102. PubMed ID: 3552473
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory activity and bactericidal kinetics of mecillinam/ampicillin combinations against Enterobacteriaceae, Pseudomonas and Acinetobacter.
Fuglesang JE; Bergan T; Bielecki T; Naterstad A; Namork E
Infection; 1981; 9(6):290-5. PubMed ID: 6277795
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of ceftazidime-pefloxacin interaction shown by a new killing curve-chequerboard method.
Drugeon HB; Caillon J; Juvin ME; Pirault JL
J Antimicrob Chemother; 1987 Feb; 19(2):197-203. PubMed ID: 3106301
[TBL] [Abstract][Full Text] [Related]
5. Synergistic and bactericidal activities of mecillinam, amoxicillin and clavulanic acid combinations against extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in 24-h time-kill experiments.
Skarp KP; Shams A; Montelin H; Lagerbäck P; Tängdén T
Int J Antimicrob Agents; 2019 Jan; 53(1):74-79. PubMed ID: 30236958
[TBL] [Abstract][Full Text] [Related]
6. In-vitro activity of the combinations of ampicillin with mecillinam or with beta-lactamase inhibitors against strains resistant to ampicillin.
Verbist L
J Antimicrob Chemother; 1985 Dec; 16(6):719-25. PubMed ID: 3879248
[TBL] [Abstract][Full Text] [Related]
7. Activity of mecillinam alone and in combination with other beta-lactam antibiotics.
Fass RJ
Antimicrob Agents Chemother; 1980 Dec; 18(6):906-12. PubMed ID: 6263179
[TBL] [Abstract][Full Text] [Related]
8. Mecillinam-ampicillin synergism in experimental Enterobacteriaceae meningitis.
Scheld WM; Fink FN; Fletcher DD; Sande MA
Antimicrob Agents Chemother; 1979 Sep; 16(3):271-6. PubMed ID: 228591
[TBL] [Abstract][Full Text] [Related]
9. Serum bactericidal activity of ceftazidime increased by netilmicin.
LeBel M; Pellerin M; Bergeron MG
Drug Intell Clin Pharm; 1985 Dec; 19(12):932-6. PubMed ID: 3910388
[TBL] [Abstract][Full Text] [Related]
10. [Effects of ampicillin and cefazolin combined with mecillinam (author's transl)].
Stille W; Bischof-Léger E; Helm EB
Arzneimittelforschung; 1978; 28(10):1661-4. PubMed ID: 226099
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
Nishino T; Otsuki M; Hatano K; Nishihara Y
Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
[TBL] [Abstract][Full Text] [Related]
12. Synergic post-antibiotic effect of mecillinam, in combination with other beta-lactam antibiotics in relation to morphology and initial killing.
Hanberger H; Nilsson LE; Svensson E; Maller R
J Antimicrob Chemother; 1991 Oct; 28(4):523-32. PubMed ID: 1761447
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of the in vitro activity of ceftazidime: in culture, in serum and in combination with granulocytes].
Daschner FD; Bassler M; Grundau D; Dieterle L; Just HM
Immun Infekt; 1983 Nov; 11(6):221-8. PubMed ID: 6439624
[TBL] [Abstract][Full Text] [Related]
14. In vitro interaction between mecillinam and piperacillin-tazobactam in the presence of azithromycin against members of the Enterobacteriaceae family and Pseudomonas aeruginosa.
Maioli E; Debbia EA; Gualco L; Marchese A
New Microbiol; 2008 Jan; 31(1):37-46. PubMed ID: 18437840
[TBL] [Abstract][Full Text] [Related]
15. In vitro combination of mecillinam with cephradine or amoxycillin for organisms resistant to single agents.
Chattopadhyay B; Hall I
J Antimicrob Chemother; 1979 Sep; 5(5):549-53. PubMed ID: 227829
[TBL] [Abstract][Full Text] [Related]
16. Characterization of synergy between ofloxacin, ceftazidime, and tobramycin against Pseudomonas aeruginosa.
Madaras-Kelly KJ; Moody J; Larsson A; Baeker Hovde L; Rotschafer JC
Chemotherapy; 1997; 43(2):108-17. PubMed ID: 9084919
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
Aktaş Z; Kayacan C; Oncul O
Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
[TBL] [Abstract][Full Text] [Related]
18. Amdinocillin: interaction with other beta-lactam antibiotics for gram-negative bacteria.
Eng RH; Liu R; Smith SM; Johnson ES; Cherubin CE
Chemotherapy; 1988; 34(1):18-26. PubMed ID: 3258230
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Pfaller MA; Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2006 Sep; 56(1):63-8. PubMed ID: 16650951
[TBL] [Abstract][Full Text] [Related]
20. Mecillinam activity compared to ampicillin, trimethoprim/sulfamethoxazole, ciprofloxacin and nitrofurantoin against urinary tract isolates of gram-negative bacilli.
Zhanel GG; Karlowsky JA; Schwartz B; Jensen SB; Hoban DJ
Chemotherapy; 1998; 44(6):391-6. PubMed ID: 9755298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
